- Home
- VMD vs ITOS Comparison
VMD vs ITOS Comparison
Compare VMD & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- ITOS
- Stock Information
- Founded
- VMD 2006
- ITOS 2011
- Country
- VMD United States
- ITOS United States
- Employees
- VMD N/A
- ITOS N/A
- Industry
- VMD
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VMD
- ITOS Health Care
- Exchange
- VMD Nasdaq
- ITOS Nasdaq
- Market Cap
- VMD 288.1M
- ITOS 270.7M
- IPO Year
- VMD N/A
- ITOS 2020
- Fundamental
- Price
- VMD $7.24
- ITOS $6.88
- Analyst Decision
- VMD
- ITOS Strong Buy
- Analyst Count
- VMD 0
- ITOS 3
- Target Price
- VMD N/A
- ITOS $26.00
- AVG Volume (30 Days)
- VMD 114.2K
- ITOS 384.6K
- Earning Date
- VMD 03-10-2025
- ITOS 03-05-2025
- Dividend Yield
- VMD N/A
- ITOS N/A
- EPS Growth
- VMD 12.00
- ITOS N/A
- EPS
- VMD 0.28
- ITOS N/A
- Revenue
- VMD $224,257,000.00
- ITOS $35,000,000.00
- Revenue This Year
- VMD $13.27
- ITOS N/A
- Revenue Next Year
- VMD $14.11
- ITOS $121.70
- P/E Ratio
- VMD $26.75
- ITOS N/A
- Revenue Growth
- VMD 22.54
- ITOS 177.89
- 52 Week Low
- VMD $6.21
- ITOS $6.67
- 52 Week High
- VMD $9.81
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- VMD 36.39
- ITOS 42.01
- Support Level
- VMD $7.32
- ITOS $6.73
- Resistance Level
- VMD $7.60
- ITOS $7.65
- Average True Range (ATR)
- VMD 0.27
- ITOS 0.36
- MACD
- VMD -0.02
- ITOS -0.01
- Stochastic Oscillator
- VMD 7.59
- ITOS 21.43
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.